Abstract
A 50% increase in the 1995 US population size by the year 2050 has been projected (1). Although 12.5% of the population was 65 years or older in 1990, it is estimated the percentage will increase to 20% by 2050 (Fig. 1). The number of elderly will increase from 39 million in 2010 to 69 million by 2030 (1). The projected population growth of older patients will certainly increase the prevalence of hypertension in the elderly, which accounts for two-thirds of the elderly population (2). The prevalence of hypertension has increased since 1988 (Fig. 2) (3).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Day JC. Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050. Washington, DC: US Government Printing Office; 1996. US Bureau of Census, Current Population Reports P25-1130.
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413–2446.
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003;290:199–206.
Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995;25:305–313.
Franklin SS, Jacobs MJ, Wong ND, L’Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869–874.
Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N EnglJ Med 2001;345:479–486.
Chobanian AV. Control of hypertension-an important national priority. N Engl J Med 2001;345:534–535.
Applegate WB. The relative importance of focusing on elevations of systolic vs diastolic blood pressure. A definitive answer at last. Arch Intern Med 1992; 152: 1969–1971.
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255–3264.
Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992;304:405–412.
Izzo JL Jr, Levy D, Black HR. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension 2000;35:1021–1024.
Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA 1994;272:1932–1938.
Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998;16(12 Pt 1): 1823–1829.
Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757–764.
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA2002;288:2981–2997.
Grimm RH Jr, Margolis KL, Papademetriou VV, et al. Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2001;37:19–27.
Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393–404.
Prisant LM, Moser M. Hypertension in the elderly: can we improve results of therapy? Arch Intern Med2000;160:283–289.
Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–2572.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Gifford, R.W., Prisant, L.M. (2005). The Importance of Hypertension in the Geriatric Population. In: Prisant, L.M. (eds) Hypertension in the Elderly. Clinical Hypertension and Vascular Diseases. Humana Press. https://doi.org/10.1007/978-1-59259-911-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-59259-911-0_1
Publisher Name: Humana Press
Print ISBN: 978-1-58829-197-4
Online ISBN: 978-1-59259-911-0
eBook Packages: MedicineMedicine (R0)